We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

78 hedge funds and large institutions have $1.1B invested in Vaxcyte in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

16% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 25

13% more capital invested

Capital invested by funds: $971M → $1.1B (+$124M)

4% more funds holding

Funds holding: 75 → 78 (+3)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

1.35% less ownership

Funds ownership: 84.12% → 82.77% (-1.4%)

Holders
78
Holders Change
+3
Holders Change %
+4%
% of All Funds
1.37%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
8
Increased
29
Reduced
25
Closed
5
Calls
$634K
Puts
–
Net Calls
+$634K
Net Calls Change
+$380K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$4.73M
2
BlackRock
BlackRock
New York
+$4.32M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.88M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.95M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.7M

Top Sellers

1
State Street
State Street
Massachusetts
-$8.9M
2
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$7.37M
3
IC
Ikarian Capital
Texas
-$3.71M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
-$1.58M
5
Citigroup
Citigroup
New York
-$1.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$3.09M +$337K +13,884 +13%
GPP
27
Great Point Partners
Connecticut
$2.49M +$2.38M +98,061 New
SM
28
Sabby Management
Florida
$1.69M -$1.25M -51,511 -44%
AAA
29
Affinity Asset Advisors
New York
$1.27M – – –
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$1.2M +$51.6K +2,127 +5%
Citadel Advisors
31
Citadel Advisors
Florida
$1.16M -$1.17M -48,263 -51%
Swiss National Bank
32
Swiss National Bank
Switzerland
$1.14M – – –
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$970K -$401K -16,552 -30%
Morgan Stanley
34
Morgan Stanley
New York
$966K +$441K +18,200 +92%
AllianceBernstein
35
AllianceBernstein
Tennessee
$941K +$167K +6,900 +23%
BFM
36
Boothbay Fund Management
New York
$753K -$471K -19,441 -40%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$729K -$136K -5,618 -16%
Deutsche Bank
38
Deutsche Bank
Germany
$727K -$24.9K -1,029 -3%
Bank of America
39
Bank of America
North Carolina
$716K -$1.22M -50,378 -64%
Rafferty Asset Management
40
Rafferty Asset Management
New York
$712K -$602K -24,827 -47%
Temasek Holdings
41
Temasek Holdings
Singapore
$692K +$661K +27,272 New
JP Morgan Chase
42
JP Morgan Chase
New York
$661K +$101K +4,176 +19%
SG Americas Securities
43
SG Americas Securities
New York
$651K +$622K +25,670 New
Citigroup
44
Citigroup
New York
$641K -$1.45M -59,741 -70%
AIG
45
American International Group
New York
$561K -$3.93K -162 -0.7%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$542K -$36.6K -1,509 -7%
EMG
47
ETF Managers Group
New Jersey
$491K +$94.6K +3,901 +26%
Invesco
48
Invesco
Georgia
$423K +$50.8K +2,095 +14%
ProShare Advisors
49
ProShare Advisors
Maryland
$414K -$78K -3,217 -16%
VOYA Investment Management
50
VOYA Investment Management
Georgia
$398K – – –
1
2
3 4

PCVX Hedge Fund Activity: Q3 2021 in Review

78 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q3 2021, worth a combined $1.1B — up 13% from $971M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PCVX positions and 5 closed out — a net gain of 3 holders — while 29 added to existing stakes and 25 trimmed.

The largest buyer was Vanguard Group, adding an estimated $4.73M. The largest seller was State Street, cutting an estimated $8.9M.

  • 78 institutional investors held Vaxcyte (PCVX) as of Q3 2021, up from 75 in Q2 2021.
  • Funds reported $1.1B of Vaxcyte stock for Q3 2021, up 13% quarter-over-quarter.
  • 8 funds opened new Vaxcyte positions in Q3 2021 and 5 closed out, a net change of +3 holders.
  • The largest Vaxcyte buyer in Q3 2021 was Vanguard Group, an estimated $4.73M added.
  • The largest Vaxcyte seller in Q3 2021 was State Street, an estimated $8.9M sold.

Based on aggregated 13F filings for Q3 2021.